BDBM199498 US10125145, Cpd. No. 11::US9670229, 11::n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo [3.3.1]nonan-7-yl)-1-(pyridin-2-yl)-1h- pyrrolo[2,3-b]pyridine-3-carboxamide, 2,2,2-trifluoroacetic acid salt

SMILES CN1C2COCC1CC(C2)NC(=O)c1cn(-c2cccnc2)c2ncccc12

InChI Key InChIKey=CZZVRBMSYUWKTG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 199498   

Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199498(US10125145, Cpd. No. 11 | US9670229, 11 | n-((1r,5...)
Affinity DataIC50:  0.600nMAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM199498(US10125145, Cpd. No. 11 | US9670229, 11 | n-((1r,5...)
Affinity DataIC50:  0.600nMT: 2°CAssay Description:The 5-HT3 antagonist activity of the compounds of the invention was determined by measuring the ability of the compounds to inhibit the calcium flux ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent